Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026)
Aytu Biopharma (AYTU) reported Cash from Operations of 4182000.0 for Q1 2026, up 35.21% year-over-year from 3092897.57 in Q1 2025, and down 213.8% quarter-over-quarter from 3675000.0 in Q4 2025.
Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 17 years of Cash from Operations data on file, last reported at 4182000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 4182000.0, up 35.21% year-over-year; the trailing twelve-month figure through Mar 2026 was 1678000.0 (up 130.35% YoY), and the FY2025 annual result was 1937000.0, down 39.55% from the prior year.
- Cash from Operations retreated to 4182000.0 in Q1 2026 per AYTU's latest filing, from 3675000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 9365000.0 in Q2 2023 and troughed at 9115000.0 in Q1 2022.
- A 5-year average of 1517000.0 and a median of 788000.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 2251.85% in 2024, then tumbled 2441.34% in 2025.
- A 5-year view of Cash from Operations shows it stood at 2500000.0 in 2022, then surged by 94.6% to 135000.0 in 2023, then surged by 2251.85% to 2905000.0 in 2024, then grew by 26.51% to 3675000.0 in 2025, then plunged by 213.8% to 4182000.0 in 2026.
- Business Quant data shows AYTU's Cash from Operations at 4182000.0 in Q1 2026, 3675000.0 in Q4 2025, and 618000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | -4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.18 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | -6.46 Mn |
| Mar 31, 2025 | -6.46 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -788,000.00 |
| Jun 30, 2024 | -788,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Dec 31, 2023 | -135,000.00 |